{"pmid":32436744,"title":"Impact of COVID-19 on reproductive health and maternity services in low resource countries.","text":["Impact of COVID-19 on reproductive health and maternity services in low resource countries.","Purpose: Coronavirus Disease-2019 (COVID-19) is a rapidly evolving pandemic. It is well-known that pregnant women are more susceptible to viral infection due to immune and anatomic factors. Therefore, the viral pandemic might affect the reproductive health and maternity services especially in low-resource countries.Materials and methods: In this article, we tried to highlight the impact of COVID-19 on reproductive health and maternity health services in low resource countries with emphasis on adapting some of the published best practice recommendations to suit a struggling environment.Conclusion: Pregnant women residing in low resource countries represent a uniquely vulnerable group in epidemics due to several factors. Maternity services in low resource countries are adapting to provide antenatal and postnatal care amidst a rapidly shifting health system environment due to the COVID-19 pandemic.","Eur J Contracept Reprod Health Care","Abdelbadee, Ahmed Y","Abbas, Ahmed M","32436744"],"abstract":["Purpose: Coronavirus Disease-2019 (COVID-19) is a rapidly evolving pandemic. It is well-known that pregnant women are more susceptible to viral infection due to immune and anatomic factors. Therefore, the viral pandemic might affect the reproductive health and maternity services especially in low-resource countries.Materials and methods: In this article, we tried to highlight the impact of COVID-19 on reproductive health and maternity health services in low resource countries with emphasis on adapting some of the published best practice recommendations to suit a struggling environment.Conclusion: Pregnant women residing in low resource countries represent a uniquely vulnerable group in epidemics due to several factors. Maternity services in low resource countries are adapting to provide antenatal and postnatal care amidst a rapidly shifting health system environment due to the COVID-19 pandemic."],"journal":"Eur J Contracept Reprod Health Care","authors":["Abdelbadee, Ahmed Y","Abbas, Ahmed M"],"date":"2020-05-22T11:00:00Z","year":2020,"_id":"32436744","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1080/13625187.2020.1768527","keywords":["covid-19","reproductive health","low-resource countries","maternity services"],"topics":["Prevention"],"weight":1,"_version_":1667521393656332289,"score":9.490897,"similar":[{"pmid":32276778,"pmcid":"PMC7141547","title":"Caring for the carers: Ensuring the provision of quality maternity care during a global pandemic.","text":["Caring for the carers: Ensuring the provision of quality maternity care during a global pandemic.","The COVID-19 pandemic is impacting health systems worldwide. Maternity care providers must continue their core business in caring and supporting women, newborns and their families whilst also adapting to a rapidly changing health system environment. This article provides an overview of important considerations for supporting the emotional, mental and physical health needs of maternity care providers in the context of the unprecedented crisis that COVID-19 presents. Cooperation, planning ahead and adequate availability of PPE is critical. Thinking about the needs of maternity providers to prevent stress and burnout is essential. Emotional and psychological support needs to be available throughout the response. Prioritising food, rest and exercise are important. Healthcare workers are every country's most valuable resource and maternity providers need to be supported to provide the best quality care they can to women and newborns in exceptionally trying circumstances.","Women Birth","Wilson, Alyce N","Ravaldi, Claudia","Scoullar, Michelle J L","Vogel, Joshua P","Szabo, Rebecca A","Fisher, Jane R W","Homer, Caroline S E","32276778"],"abstract":["The COVID-19 pandemic is impacting health systems worldwide. Maternity care providers must continue their core business in caring and supporting women, newborns and their families whilst also adapting to a rapidly changing health system environment. This article provides an overview of important considerations for supporting the emotional, mental and physical health needs of maternity care providers in the context of the unprecedented crisis that COVID-19 presents. Cooperation, planning ahead and adequate availability of PPE is critical. Thinking about the needs of maternity providers to prevent stress and burnout is essential. Emotional and psychological support needs to be available throughout the response. Prioritising food, rest and exercise are important. Healthcare workers are every country's most valuable resource and maternity providers need to be supported to provide the best quality care they can to women and newborns in exceptionally trying circumstances."],"journal":"Women Birth","authors":["Wilson, Alyce N","Ravaldi, Claudia","Scoullar, Michelle J L","Vogel, Joshua P","Szabo, Rebecca A","Fisher, Jane R W","Homer, Caroline S E"],"date":"2020-04-12T11:00:00Z","year":2020,"_id":"32276778","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.1016/j.wombi.2020.03.011","keywords":["covid-19","emotional and psychological support","maternity care providers","maternity services","pandemic preparedness"],"topics":["Prevention"],"weight":1,"_version_":1666138491646377985,"score":308.26532},{"pmid":32219871,"title":"Maternal health care management during the outbreak of coronavirus disease 2019.","text":["Maternal health care management during the outbreak of coronavirus disease 2019.","Coronavirus disease 2019 (COVID-19) is a novel type of highly contagious pneumonia caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Despite the strong efforts taken to control the epidemic, hundreds of thousands of people were infected worldwide by 11 March, and the situation was characterized as a pandemic by the World Health Organization. Pregnant women are more susceptible to viral infection due to immune and anatomic alteration, though hospital visits may increase the chance of infection, the lack of medical care during pregnancy may do more harm. Hence, a well-managed system that allows pregnant women to access maternal health care with minimum exposure risk is desired during the outbreak. Here, we present the managing processes of three pregnant women who had fever during hospitalization in the gynecology or obstetrics department, and then, we further summarize and demonstrate our maternal health care management strategies including antenatal care planning, patient triage based on the risk level, admission control, and measures counteracting emergencies and newly discovered high-risk cases at in-patient department. In the meantime, we will explain the alterations we have done throughout different stages of the epidemic and also review relative articles in both Chinese and English to compare our strategies with those of other areas. Although tens of COVID-19 cases were confirmed in our hospital, no nosocomial infection has occurred and none of the pregnant women registered in our hospital was reported to be infected.","J Med Virol","Chen, Yu","Li, Zhe","Zhang, Yuan-Yuan","Zhao, Wei-Hua","Yu, Zhi-Ying","32219871"],"abstract":["Coronavirus disease 2019 (COVID-19) is a novel type of highly contagious pneumonia caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Despite the strong efforts taken to control the epidemic, hundreds of thousands of people were infected worldwide by 11 March, and the situation was characterized as a pandemic by the World Health Organization. Pregnant women are more susceptible to viral infection due to immune and anatomic alteration, though hospital visits may increase the chance of infection, the lack of medical care during pregnancy may do more harm. Hence, a well-managed system that allows pregnant women to access maternal health care with minimum exposure risk is desired during the outbreak. Here, we present the managing processes of three pregnant women who had fever during hospitalization in the gynecology or obstetrics department, and then, we further summarize and demonstrate our maternal health care management strategies including antenatal care planning, patient triage based on the risk level, admission control, and measures counteracting emergencies and newly discovered high-risk cases at in-patient department. In the meantime, we will explain the alterations we have done throughout different stages of the epidemic and also review relative articles in both Chinese and English to compare our strategies with those of other areas. Although tens of COVID-19 cases were confirmed in our hospital, no nosocomial infection has occurred and none of the pregnant women registered in our hospital was reported to be infected."],"journal":"J Med Virol","authors":["Chen, Yu","Li, Zhe","Zhang, Yuan-Yuan","Zhao, Wei-Hua","Yu, Zhi-Ying"],"date":"2020-03-29T11:00:00Z","year":2020,"_id":"32219871","source":"PubMed","week":"202013|Mar 23 - Mar 29","doi":"10.1002/jmv.25787","keywords":["2019 coronavirus disease","2019 novel coronavirus","antenatal care","health care management","maternal health","nosocomial infection","pregnant","severe acute respiratory syndrome coronavirus 2"],"weight":0,"_version_":1666138492282863616,"score":267.47556},{"pmid":32238177,"pmcid":"PMC7112750","title":"Emerging infectious diseases and outbreaks: implications for women's reproductive health and rights in resource-poor settings.","text":["Emerging infectious diseases and outbreaks: implications for women's reproductive health and rights in resource-poor settings.","This century is witnessing dramatic changes in the health needs of the world's populations. The double burden of infectious and chronic diseases constitutes major causes of morbidity and mortality. Over the last two decades, there has been a rise in infectious diseases, including the severe acute respiratory syndrome virus (SARS), the H1N1 pandemic influenza, the Ebolavirus and the Covid-19 virus. These diseases have rapidly spread across the world and have reminded us of the unprecedented connectivity that defines our modern civilization. Though some countries have made substantial progress toward improving global surveillance for emerging infectious diseases (EIDs), the vast majority of Low-and Middle-income Countries (LMICs) with fragile health systems and various system-related bottlenecks remain vulnerable to outbreaks and, as such, experience dramatic social and economic consequences when they are reported. Lessons learned from past outbreaks suggest that gender inequalities are common across a range of health issues relating to Sexual and Reproductive Health and Rights (SRHR), with women being particularly disadvantaged, partially due to the burden placed on them. Though these countries are striving to improve their health systems and be more inclusive to this vulnerable group, the national/ global outbreaks have burdened the overall system and thus paralyzed normal services dedicated to the delivery of Sexual and Reproductive Health (SRH) services. In this paper, we discuss the global commitments to SRH, the impact of the EIDs on the LMICs, the failure in the delivery of SRH services, and the strategies for successful implementation of recovery plans that must address the specific and differentiated needs of women and girls in resource-poor settings.","Reprod Health","Chattu, Vijay Kumar","Yaya, Sanni","32238177"],"abstract":["This century is witnessing dramatic changes in the health needs of the world's populations. The double burden of infectious and chronic diseases constitutes major causes of morbidity and mortality. Over the last two decades, there has been a rise in infectious diseases, including the severe acute respiratory syndrome virus (SARS), the H1N1 pandemic influenza, the Ebolavirus and the Covid-19 virus. These diseases have rapidly spread across the world and have reminded us of the unprecedented connectivity that defines our modern civilization. Though some countries have made substantial progress toward improving global surveillance for emerging infectious diseases (EIDs), the vast majority of Low-and Middle-income Countries (LMICs) with fragile health systems and various system-related bottlenecks remain vulnerable to outbreaks and, as such, experience dramatic social and economic consequences when they are reported. Lessons learned from past outbreaks suggest that gender inequalities are common across a range of health issues relating to Sexual and Reproductive Health and Rights (SRHR), with women being particularly disadvantaged, partially due to the burden placed on them. Though these countries are striving to improve their health systems and be more inclusive to this vulnerable group, the national/ global outbreaks have burdened the overall system and thus paralyzed normal services dedicated to the delivery of Sexual and Reproductive Health (SRH) services. In this paper, we discuss the global commitments to SRH, the impact of the EIDs on the LMICs, the failure in the delivery of SRH services, and the strategies for successful implementation of recovery plans that must address the specific and differentiated needs of women and girls in resource-poor settings."],"journal":"Reprod Health","authors":["Chattu, Vijay Kumar","Yaya, Sanni"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32238177","source":"PubMed","week":"202014|Mar 30 - Apr 05","doi":"10.1186/s12978-020-0899-y","keywords":["covid-19","ebola","emerging and re-emerging infectious diseases (eids)","gender","low- and middle-income countries (lmics)","sars","sexual and reproductive health and rights (srhrs)","sustainable developmental goals (sdgs)","women","zika"],"locations":["Ebolavirus"],"weight":0,"_version_":1666138490449952768,"score":231.62529},{"pmid":32343244,"title":"Estimates of the Potential Impact of the COVID-19 Pandemic on Sexual and Reproductive Health In Low- and Middle-Income Countries.","text":["Estimates of the Potential Impact of the COVID-19 Pandemic on Sexual and Reproductive Health In Low- and Middle-Income Countries.","The novel coronavirus (SARS-CoV-2) that causes COVID-19 has spread rapidly since emerging in late 2019, leading the World Health Organization (WHO) to declare the disease a global pandemic on March 11, 2020. Governments around the world have had to quickly adapt and respond to curb transmission of the virus and to provide care for the many who have been infected. The strain that the outbreak imposes on health systems will undoubtedly impact the sexual and reproductive health of individuals living in low- and middle-income countries (LMICs); however, sexual and reproductive health will also be affected by societal responses to the pandemic, such as local or national lockdowns that force health services to shut down if they are not deemed essential, as well as the consequences of physical distancing, travel restrictions and economic slowdowns.","Int Perspect Sex Reprod Health","Riley, Taylor","Sully, Elizabeth","Ahmed, Zara","Biddlecom, Ann","32343244"],"abstract":["The novel coronavirus (SARS-CoV-2) that causes COVID-19 has spread rapidly since emerging in late 2019, leading the World Health Organization (WHO) to declare the disease a global pandemic on March 11, 2020. Governments around the world have had to quickly adapt and respond to curb transmission of the virus and to provide care for the many who have been infected. The strain that the outbreak imposes on health systems will undoubtedly impact the sexual and reproductive health of individuals living in low- and middle-income countries (LMICs); however, sexual and reproductive health will also be affected by societal responses to the pandemic, such as local or national lockdowns that force health services to shut down if they are not deemed essential, as well as the consequences of physical distancing, travel restrictions and economic slowdowns."],"journal":"Int Perspect Sex Reprod Health","authors":["Riley, Taylor","Sully, Elizabeth","Ahmed, Zara","Biddlecom, Ann"],"date":"2020-04-29T11:00:00Z","year":2020,"_id":"32343244","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1363/46e9020","topics":["Prevention"],"weight":1,"_version_":1666138495818661888,"score":228.94739},{"pmid":32328850,"pmcid":"PMC7178925","title":"Analysis of the susceptibility to COVID-19 in pregnancy and recommendations on potential drug screening.","text":["Analysis of the susceptibility to COVID-19 in pregnancy and recommendations on potential drug screening.","To analyze the susceptibility of SARS-CoV-2 in pregnancy and the drugs that can be used to treat pregnancy with COVID-19, so as to provide evidence for drug selection in clinic. By reviewing the existing literature, this paper analyzes the susceptibility of pregnant women to virus, especially to SARS-CoV-2, from the aspects of anatomical, reproductive endocrine and immune changes during pregnancy and screens effective and fetal-safe treatments from the existing drugs. The anatomical structure of the respiratory system is changed during pregnancy, and the virus transmitted by droplets and aerosols is more easily inhaled by pregnant women and is difficult to remove. Furthermore, the prognosis is worse after infection when compared with non-pregnancy women. And changes in reproductive hormones and immune systems during pregnancy collectively make them more susceptible to certain infections. More importantly, angiotensin-converting enzyme (ACE)-2, the SARS-CoV-2 receptor, has been proven highly increased during pregnancy, which may contribute to the susceptibility to SARS-CoV-2. When it comes to treatment, specific drugs for COVID-19 have not been found at present, and taking old drugs for new use in treating COVID-19 has become an emergency method for the pandemic. Particularly, drugs that show superior maternal and fetal safety are worthy of consideration for pregnant women with COVID-19, such as chloroquine, metformin, statins, lobinavir/ritonavir, glycyrrhizic acid, and nanoparticle-mediated drug delivery (NMDD), etc. Pregnant women are susceptible to COVID-19, and special attention should be paid to the selection of drugs that are both effective for maternal diseases and friendly to the fetus. However, there are still many deficiencies in the study of drug safety during pregnancy, and broad-spectrum, effective and fetal-safe drugs for pregnant women need to be developed so as to cope with more infectious diseases in the future.","Eur J Clin Microbiol Infect Dis","Zhao, Xiaoxuan","Jiang, Yuepeng","Zhao, Yang","Xi, Hongyan","Liu, Chang","Qu, Fan","Feng, Xiaoling","32328850"],"abstract":["To analyze the susceptibility of SARS-CoV-2 in pregnancy and the drugs that can be used to treat pregnancy with COVID-19, so as to provide evidence for drug selection in clinic. By reviewing the existing literature, this paper analyzes the susceptibility of pregnant women to virus, especially to SARS-CoV-2, from the aspects of anatomical, reproductive endocrine and immune changes during pregnancy and screens effective and fetal-safe treatments from the existing drugs. The anatomical structure of the respiratory system is changed during pregnancy, and the virus transmitted by droplets and aerosols is more easily inhaled by pregnant women and is difficult to remove. Furthermore, the prognosis is worse after infection when compared with non-pregnancy women. And changes in reproductive hormones and immune systems during pregnancy collectively make them more susceptible to certain infections. More importantly, angiotensin-converting enzyme (ACE)-2, the SARS-CoV-2 receptor, has been proven highly increased during pregnancy, which may contribute to the susceptibility to SARS-CoV-2. When it comes to treatment, specific drugs for COVID-19 have not been found at present, and taking old drugs for new use in treating COVID-19 has become an emergency method for the pandemic. Particularly, drugs that show superior maternal and fetal safety are worthy of consideration for pregnant women with COVID-19, such as chloroquine, metformin, statins, lobinavir/ritonavir, glycyrrhizic acid, and nanoparticle-mediated drug delivery (NMDD), etc. Pregnant women are susceptible to COVID-19, and special attention should be paid to the selection of drugs that are both effective for maternal diseases and friendly to the fetus. However, there are still many deficiencies in the study of drug safety during pregnancy, and broad-spectrum, effective and fetal-safe drugs for pregnant women need to be developed so as to cope with more infectious diseases in the future."],"journal":"Eur J Clin Microbiol Infect Dis","authors":["Zhao, Xiaoxuan","Jiang, Yuepeng","Zhao, Yang","Xi, Hongyan","Liu, Chang","Qu, Fan","Feng, Xiaoling"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32328850","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1007/s10096-020-03897-6","keywords":["antiviral treatment","fetal safety","new coronavirus disease","pregnancy","virus susceptibility"],"e_drugs":["Metformin","Chloroquine","Glycyrrhizic Acid"],"topics":["Treatment"],"weight":1,"_version_":1666138494632722434,"score":221.79416}]}